This is a $3,119,876.00 definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to General Electric Company (GE) for the development of a "PORTABLE, REAL TIME, SINGLE CELL ANTIMICROBIAL SUSCEPTIBILITY TESTING" system. The contract has a period of performance through December 1, 2018 and uses a cost-no-fee pricing type. GE's GE Research division is the performing entity, and the contract was not set aside for small businesses. This award is part of GE's broader federal...
This is a $483,396.26 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to General Electric Company (GE) for the "BAA GE GLOBAL RESEARCH" project. The contract has no set-aside designation and was awarded on August 17, 2015, with a completion date of November 17, 2017. GE, through its GE Research division, is providing a range of advanced research, engineering, and technology development services to the CDC. GE Research has a long...
This firm-fixed-price definitive contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to General Electric Company (GE) for the "GE ULTRASOUND STIMULATED IMMUNE RESPONSE PROFILES (STIMRESPONSE): NEW TOOL FOR PRE-SYMPTOMATIC PATHOGEN EXPOSURE DETECTION" program. The $700,000.00 contract has a completion date of March 31, 2022 and does not have a small business set-aside designation. As a prime...
General Electric Company, through its GE Research Division, was awarded a $1.9 million cost-plus-fixed-fee contract by the Defense Threat Reduction Agency to conduct hazard mapping aerial radiation activities. The work directly responds to the agency's broad agency announcement seeking proposals to develop new nuclear detection technologies that improve capabilities in areas such as search, standoff detection, sensitive site exploitation, threat diagnostics and characterization, consequence...
The Defense Threat Reduction Agency awarded General Electric Company a $2.7 million definitive cost-no-fee contract to develop air-deployable cost-effective organic radiation nodes under its broad agency announcement seeking new nuclear detection technologies. The contract supports DTRA's goal of improving capabilities in areas such as search, standoff detection, sensitive site exploitation, threat diagnostics and characterization, consequence management, contamination avoidance, and...
This is a $5,222,170 cost-no-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The contract is for a base period with a completion date of June 19, 2020 and does not have a set-aside designation. The objective of the contract is to develop a T cell-based vaccine for Q fever (Coxiella burnetii). MGH is the prime contractor, with multiple subcontractors including the...
This is a $1,732,346.00 Other Transaction Agreement awarded by the Defense Advanced Research Projects Agency (DARPA) to General Electric Company (GE) to provide research and development services for "Grounding Natural Language in AI Worlds". The contract is not set aside for any special business category. GE, a large for-profit manufacturer, is the prime contractor and has an extensive history of federal contract work, including as a subcontractor providing engineering, integration,...
This is a $3,878,757.00 cost-plus-fixed-fee contract awarded by the Department of the Navy Naval Supply Systems Command Engineering Logistics Office to General Electric Company (GE) for research and development services. The contract was awarded on February 18, 2008 with a completion date of June 15, 2011 and does not have a set-aside designation. As a prime contractor, GE has extensive experience providing a wide range of advanced technology services to federal agencies including the Department...
This is a $208,603 definitive contract awarded by the Air Force Research Laboratory (AFRL) to General Electric (GE) Company's GE Research Division. The contract is for the extrusion of high-temperature polymer resins to enable additive manufacturing of functional composites, referencing the original Broad Agency Announcement (BAA) with identification RQKM-2014-0003. The contract does not have a set-aside designation. GE Research has a history of conducting advanced research and development...
This federal contract award, valued at $28,836,234.91, was issued by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The contract is for stability testing of the RF1V plague vaccine and RBV A/B botulism vaccine drug products, drug substances, reference materials, and other critical reagents. The effort involves ongoing stability testing, reporting, and...